There are no significant Insider Shareholders in Maze Therapeutics as of December 12, 2025.
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Rock Ventures Iv, L.P. Third | 5,424,758 | 05 Nov, 2025 | |
| Jonathan E Lim | 307,956 | 04 Feb, 2025 | |
| Charles J Homcy | 38,535 | 21 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 19 Nov, 2025 | Charles J Homcy | Common Stock | A | 1,489 | $0.00 | 31,113 | D | J |
| 04 Nov, 2025 | Rock Ventures Iv, L.P. Third | Common Stock | D | 1,600,000 | - | 4,473,958 | D | J |
| 23 Oct, 2025 | Charles J Homcy | Common Stock | D | 28,423 | $0.00 | 29,624 | D | G |
| 15 Sep, 2025 | Richard H Scheller | Common Stock | D | 20,744 | $22.37 | 0 | D | S |
| 15 Sep, 2025 | Richard H Scheller | - | - | 0 | D | |||
| 03 Feb, 2025 | Charles J Homcy | - | - | 37,330 | D | |||
| 03 Feb, 2025 | Rock Ventures Iv, L.P. Third | Common Stock | A | 5,762,788 | $0.00 | 6,073,958 | D | C |
| 03 Feb, 2025 | Jonathan E Lim | Common Stock | A | 37,724 | - | 37,724 | I | C |
| 03 Feb, 2025 | Charles J Homcy | Common Stock | A | 8,807 | - | 37,330 | D | C |
| 03 Feb, 2025 | Rock Ventures Iv, L.P. Third | Common Stock | A | 950,800 | $0.00 | 950,800 | I | C |
| 03 Feb, 2025 | Charles J Homcy | Common Stock | A | 20,717 | - | 58,047 | D | C |
| 03 Feb, 2025 | Jonathan E Lim | Common Stock | A | 270,232 | - | 307,956 | I | C |
| 03 Feb, 2025 | Charles J Homcy | - | - | 58,047 | D | |||
| 03 Feb, 2025 | Charles J Homcy | - | - | 7,422 | I | |||
| 03 Feb, 2025 | Charles J Homcy | Common Stock | A | 7,422 | - | 7,422 | I | C |